📣 VC round data is live. Check it out!
- Public Comps
- Ambea
Ambea Valuation Multiples
Discover revenue and EBITDA valuation multiples for Ambea and similar public comparables like Ship Healthcare Holdings, Ryman Healthcare, Regis Healthcare, Summerset Group Holdings and more.
Ambea Overview
About Ambea
Ambea AB is a provider of care in Sweden focused on disabled and elderly residential care in its own management units. The company's segment includes Nytida, Vardaga, Stendi, Altiden, and Klara. The Vardaga segment provides elderly care. The Nytida segment offers disability care. The Stendi segment comprises support for children and young people, personal assistance, residential care facilities, elderly care, and home care in Norway. The Altiden segment comprises operations in elderly care and home care; The Klara segment engages in staffing such as temporary doctors, nurses, and other care workers.
Founded
1903
HQ

Employees
35.0K
Website
Sectors
Financials (LTM)
EV
$3B
Valuation Multiples
Start free trialAmbea Financials
Ambea reported last 12-month revenue of $2B and EBITDA of $332M.
In the same LTM period, Ambea generated $318M in gross profit, $332M in EBITDA, and $80M in net income.
Revenue (LTM)
Ambea P&L
In the most recent fiscal year, Ambea reported revenue of $2B and EBITDA of $324M.
Ambea is profitable as of last fiscal year, with gross margin of 91%, EBITDA margin of 18%, and net margin of 4%.
Financial data powered by Morningstar, Inc.
Ambea Stock Performance
Ambea has current market cap of $1B, and enterprise value of $3B.
Market Cap Evolution
Ambea's stock price is $15.53.
Ambea share price increased by 3.1% in the last 30 days, and by 34.6% in the last year.
Ambea has an EPS (earnings per share) of $0.93.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $1B | -1.4% | 3.1% | 9.3% | 34.6% | $0.93 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAmbea Valuation Multiples
Ambea trades at 1.5x EV/Revenue multiple, and 8.0x EV/EBITDA.
EV / Revenue (LTM)
Ambea Financial Valuation Multiples
As of May 16, 2026, Ambea has market cap of $1B and EV of $3B.
Ambea has a P/E ratio of 15.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ambea Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Ambea Margins & Growth Rates
Ambea grew revenue by 1% and EBITDA by 6% in the last fiscal year.
In the most recent fiscal year, Ambea reported gross margin of 91%, EBITDA margin of 18%, and net margin of 4%.
Ambea Margins
Ambea Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Ambea Operational KPIs
Ambea's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Ambea's Rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ambea's Rule of X is 37% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Ambea Competitors
Ambea competitors include Ship Healthcare Holdings, Ryman Healthcare, Regis Healthcare, Summerset Group Holdings, Healthcare Services Group, Omada Health, InnovAge, Attendo, Aveanna Healthcare and Addus HomeCare.
Most Ambea public comparables operate across Long-Term Care.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.2x | 0.2x | 4.6x | 4.6x | |||
| 2.7x | 2.5x | (79.7x) | 26.3x | |||
| 3.4x | 2.9x | 16.4x | 30.0x | |||
| 7.9x | 7.5x | 12.4x | 13.8x | |||
| 0.7x | 0.7x | 12.2x | 11.5x | |||
| 3.0x | 2.8x | 122.1x | 74.3x | |||
| 1.1x | 1.0x | 26.8x | 11.9x | |||
| 1.5x | 1.6x | 7.6x | 7.6x | |||
This data is available for Pro users. Sign up to see all Ambea competitors and their valuation data. Start Free Trial | ||||||
Ambea Funding History
Before going public, Ambea raised $99M in total equity funding, across 2 rounds.
Last private valuation of Ambea was $851M, after raising $43M in March 2024.
Ambea Funding Rounds
Ambea M&A Activity
Ambea has acquired 5 companies to date.
Last acquisition by Ambea was on March 12th 2025. Ambea acquired Validia for $133M (EV/Revenue multiple of ).
Latest Acquisitions by Ambea
| Description | Validia is a Finnish provider of rehabilitation and housing services, headquartered in Helsinki. It offers physiotherapy, pool therapy, occupational therapy, and assistive technology assessments for over 5,000 clients annually, operating 20 facilities across Finland with partnerships in public healthcare. | SkolPool is a Stockholm-based staffing agency specializing in substitute teachers and childcare assistants for Swedish municipalities and private schools. The platform matches certified educators with short-term and long-term positions, handling recruitment, payroll, and on-site support. It serves over 100 schools in the Stockholm region, providing coverage for preschool through high school levels with vetted professionals trained in special needs education. | — | TBO-Helse is a Norwegian private care provider specializing in disability support services including personal assistance, respite care, and housing adaptations. Operating from Oslo, the company employs over 200 staff serving clients in southeast Norway under municipal contracts. | |
| HQ Country | |||||
| HQ City | Helsinki | Stockholm | — | Oslo | |
| Deal Date | 12 Mar 2025 | 11 Apr 2022 | 16 Oct 2018 | 10 Jan 2017 | |
| Valuation | $133M | undisclosed | $250M | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Ambea acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ambea
| When was Ambea founded? | Ambea was founded in 1903. |
| Where is Ambea headquartered? | Ambea is headquartered in Sweden. |
| How many employees does Ambea have? | As of today, Ambea has over 35K employees. |
| Who is the CEO of Ambea? | Ambea's CEO is Mark Jensen. |
| Is Ambea publicly listed? | Yes, Ambea is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Ambea? | Ambea trades under AMBEA ticker. |
| When did Ambea go public? | Ambea went public in 2017. |
| Who are competitors of Ambea? | Ambea main competitors include Ship Healthcare Holdings, Ryman Healthcare, Regis Healthcare, Summerset Group Holdings, Healthcare Services Group, Omada Health, InnovAge, Attendo, Aveanna Healthcare, Addus HomeCare. |
| What is the current market cap of Ambea? | Ambea's current market cap is $1B. |
| What is the current revenue of Ambea? | Ambea's last 12 months revenue is $2B. |
| What is the current revenue growth of Ambea? | Ambea revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Ambea? | Current revenue multiple of Ambea is 1.5x. |
| Is Ambea profitable? | Yes, Ambea is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ambea? | Ambea's last 12 months EBITDA is $332M. |
| What is Ambea's EBITDA margin? | Ambea's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Ambea? | Current EBITDA multiple of Ambea is 8.0x. |
| What is the current FCF of Ambea? | Ambea's last 12 months FCF is $162M. |
| What is Ambea's FCF margin? | Ambea's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Ambea? | Current FCF multiple of Ambea is 16.3x. |
| How many companies Ambea has acquired to date? | As of May 2026, Ambea has acquired 5 companies. |
| What was the largest acquisition by Ambea? | $250M acquisition of Aleris AB on 16th October 2018 was the largest M&A Ambea has done to date. |
| What companies Ambea acquired? | Ambea acquired Aleris AB, Validia, TBO-Helse, SkolPool, and Solhagagruppen. |
| In how many companies Ambea has invested to date? | Ambea hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Ambea
Lists including Ambea
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.


